EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter Study

Rundong Qin iD, Yan Feng iD, Huanping Zhang iD, Beibei Zhao iD, Wei Lei iD, Hongying Sun iD, Lili Zhi iD, Zhongsheng Zheng iD, Siqin Wang iD, Yafeng Yu iD, Shengxue Jiang iD, Changshan Liu iD und 15 weitere

JMIR Public Health and Surveillance · 2024

DOI: 10.2196/50846 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JMIR Public Health and Surveillance, 2024. Verfasst von Rundong Qin und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease…. Hauptthemen laut MEDLINE: Rhinitis, Allergic, COVID-19, Asthma, Desensitization, Immunologic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic diseases are associated with an increased susceptibility to respiratory tract infections. Although allergen immunotherapy (AIT) alters the course of allergies, there is limited evidence from clinical practice demonstrating its ability to enhance the host defense against pathogens.

Objective

The aim of this study was to investigate the protective effect of AIT against viral infection in patients with allergic rhinitis (AR) and allergic asthma (AS) based on clinical evidence.

Methods

A multicenter, questionnaire-based survey was conducted during a tremendous surge in COVID-19 cases between February 10, 2023, and March 15, 2023, in 81 centers across China recruiting healthy volunteers and patients with AR and AS to investigate the clinical outcomes of COVID-19 infection.

Results

Of 10,151 participants recruited in the survey, 3654 patients and 2192 healthy volunteers who tested positive for COVID-19 were included in this analysis after screening. Overall, no significant differences in COVID-19 outcomes were observed between patients and healthy volunteers. An additional 451 patients were excluded due to their use of biologics as the sole add-on treatment, leaving 3203 patients in the further analysis. Of them, 1752 were undergoing routine medication treatment (RMT; the RMT group), whereas 1057 and 394 were receiving AIT and a combination of AIT and omalizumab (OMA) as adjunct therapies to RMT, respectively (AIT+RMT and AIT+OMA+RMT groups). The AIT group showed milder COVID-19 symptoms, shorter recovery periods, and a lower likelihood of hospitalization or emergency department visits than the RMT group (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, AllergicCOVID-19AsthmaDesensitization, ImmunologicHumansMaleFemaleAdultMiddle AgedChinaYoung AdultAdolescentAgedSurveys and Questionnaires

Stichwörter der Autor:innen

COVID-19allergen immunotherapyallergic diseaseallergic rhinitisantiviral effectasthmaclinical evidencequestionnaire-based surveytrajectoryviral infection

Autor:innen und Institutionen

  • Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hosp…
  • Department of Otolaryngology Head and Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, China.
  • Department of Allergology, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Shanxi, China.
  • Department of Allergy, The Second Affiliated Hospital of Dalian Medical University, Liaoning, China.
  • Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Pulmonary and Critical Care Medicine, The First Hospital of Jilin University, Changchun, China.

ORCID-Profile: Rundong Qin, Yan Feng, Huanping Zhang, Beibei Zhao, Wei Lei, Hongying Sun, Lili Zhi, Zhongsheng Zheng, Siqin Wang, Yafeng Yu, Shengxue Jiang, Changshan Liu, Xingkai Ma, Hui Ma, Huiying Wang, Hang Lin, Qiaojie He, Lingying Wu, Yingying Zhai, Honglue Lu, Shi Chen, Yan Ma, Xiaohong Jin, Shan Deng, Nanshan Zhong, Ruchong Chen, Jing Li

Zitieren

APA

Qin, R., Feng, Y., Zhang, H., Zhao, B., Lei, W., Sun, H., Zhi, L., Zheng, Z., Wang, S., Yu, Y., Jiang, S., Liu, C., Ma, X., Ma, H., Wang, H., Lin, H., He, Q., Wu, L., Zhai, Y., …, & Li, J. (2024). Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/50846

Vancouver

Qin R, Feng Y, Zhang H, Zhao B, Lei W, Sun H, et al. Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter Study. JMIR Public Health and Surveillance. 2024. doi:10.2196/50846

BibTeX
@article{Qin2024,
  author = {Qin, Rundong and Feng, Yan and Zhang, Huanping and Zhao, Beibei and Lei, Wei and Sun, Hongying and Zhi, Lili and Zheng, Zhongsheng and Wang, Siqin and Yu, Yafeng and Jiang, Shengxue and Liu, Changshan and Ma, Xingkai and Ma, Hui and Wang, Huiying and Lin, Hang and He, Qiaojie and Wu, Lingying and Zhai, Yingying and Lu, Honglue and Chen, Shi and Ma, Yan and Jin, Xiaohong and Deng, Shan and Zhong, Nanshan and Chen, Ruchong and Li, Jing},
  title = {Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2024},
  doi = {10.2196/50846}
}
Kostenlos starten →